Navigation Links
Biomerix Ventral Hernia Repair Mesh Receives FDA 510(k) Clearance
Date:6/30/2010

FREMONT, Calif., June 30 /PRNewswire/ -- Biomerix Corporation announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) Clearance to market its Biomerix Ventral Hernia Repair Mesh, the latest addition to its innovative portfolio of soft tissue repair devices. The Biomerix Ventral Hernia Repair Mesh, with two distinctly different sides, is the first and only device featuring the Biomerix Biomaterial™ on one side, designed to promote tissue ingrowth, and a resorbable protective film on the other side, designed to minimize tissue attachment to the device in case of direct contact with the viscera. It is indicated for use in hernias and soft tissue deficiencies and for the temporary bridging of fascial defects.

More than 400,000 people suffer from ventral hernias in the U.S. today. A ventral hernia is a lump in the abdomen, usually a tissue bulge or a small area of swelling. Ventral hernia is also referred to as an incisional hernia, since it can occur in the area of any prior surgical incision. An aging population and a growing number of obese patients are contributing to the rising incidence of ventral hernias. Current product solutions are unable to address the high recurrence rates and the increased risk of adhesion formation commonly associated with ventral hernia repair. The Biomerix Ventral Hernia Repair Mesh is constructed to support tissue ingrowth. The state-of-the-art design provides a resorbable protective film on one side to act as barrier, minimizing the risk of adhesions to the device. By incorporating the Biomerix Biomaterial™ platform, the Ventral Hernia Repair Mesh's soft and pliable design offers surgeons conformability for acute performance in both open and laparoscopic procedures.

"The FDA clearance of the Biomerix Ventral Hernia Repair Mesh represents the next generation in ventral and incisional hernia repair prosthesis. We believe the novel Biomerix Biomaterial has desirable scaffold features leading to successful repair outcomes, making it a compelling alternative to other synthetic biomaterials," stated Kenneth G. Hayes, President and Chief Executive Officer of Biomerix Corporation.

About Biomerix Corporation

Biomerix Corporation develops and manufactures novel materials for the medical, industrial, and consumer markets.  The Company has successfully developed a synthetic biomaterial platform, the Biomerix Biomaterial™. It is a non-resorbable, polycarbonate polyurethane-urea, biointegrative tissue scaffold. Unique to the Biomerix Biomaterial™, is its ability to facilitate fibrovascular tissue in-growth and improve wound healing, leading to better clinical outcomes.

For more information please call 888.308.3620 or visit www.biomerix.com.


'/>"/>
SOURCE Biomerix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Global Hernia Repair Devices Industry
2. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
3. PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects
4. CorMatrix(R) ECM(TM) Receives CE Mark for Cardiac Tissue Repair
5. Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation
6. July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook, Bells Palsy and Heart Valve Repair
7. GreenBytes Wards Off Germs and Costly Computer Repairs
8. Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting
9. VirtualScopics Quantitative Imaging Provides Primary Endpoint in Cartilage Repair Pivotal Clinical Trial
10. March 2009 Mayo Clinic Health Letter Highlights Knee Repair Surgery, Anxiety Disorder and Preventing Blood Clots
11. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals ... the field of eating disorders, announces the opening of early registration for the ... at the Omni Resort at ChampionsGate. , The annual iaedp™ Symposium ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
Breaking Medicine News(10 mins):